SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001424422-19-000003
Filing Date
2019-02-21
Accepted
2019-02-21 18:35:48
Documents
1
Period of Report
2019-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 10400
  Complete submission text file 0001424422-19-000003.txt   11806
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1579 MAIN ST SOUTHLAKE TX 76092
Business Address
Plott Ronald Todd (Reporting) CIK: 0001768337 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37411 | Film No.: 19623437